Shanghai's SARI Pays $359M for Italian Cancer Biopharma NMS Post author:Sam Post published:December 28, 2017 Post category:BioPharma The parts expect the closing in the first quarter 2018. Source: BioSpace You Might Also Like Insmed Rockets as Lung Drug Wows in Late-Stage Study September 4, 2017 Vertex Quietly Terminates a Small Phase II CF Trial September 11, 2017 Sanofi Pasteur Inks $645 Million RSV Deal With AstraZeneca PLC's MedImmune March 2, 2017
